FROM THE CLOSED TO THE OPEN INNOVATION MODEL BY PHARMOCHEMICAL PHARMACEUTICAL BRAZILIAN INDUSTRY. WHAT DOES THE TRANSACTION COSTS MATTER?
Departing from analytical framework of the relationship between open innovation and the analytical lines of the neoinstitutional organization theory, the main goal of this study is to contribute to the advance in understanding these theories. These advances will occur to the extent that, in this text, propositions will be developed relating important dimensions of the transaction costs theory, with the innovative performance of partnerships and the intensity and variety with which firms develop partnerships with external sources of knowledge. The propositions can be empirically tested as hypotheses in future research. Therefore the PINTEC/IBGE dataset, specifically the brasilian manufacturing industry which covered the period between 2000-2011 was used. The methods applied here, firstly, extracted from the dataset some proxy variables that represent the theoretical constructs studied here and related to the innovative activities of each of the sectors. Second, three classification criteria were created, regard to a statistical descriptive of these construct’s indicators, in order to select a particular industry. The brasilian pharmochemical pharmaceutical industry was selected to develop the analysis. From the institutional environment that impacted and was impacted by this industry, the possible connections between the dimensions of the transaction costs theory and the open innovation theory were proposed. Such connections were treated as important variables which can influence the probable migration of the cited industry, from the closed model to the open innovation model.